PURPOSE/ OBJECTIVES: To assess dietary supplement use and its association with demographic and health-related characteristics among cancer survivors and to investigate differences in supplement use patterns by cancer site. DESIGN: A cross-sectional survey. SETTING: Computer-assisted telephone survey. SAMPLE: 1,233 adult (ages 30-69) survivors participating in the Penn State Cancer Survivor Study who underwent an interviewer-administered questionnaire. METHODS: Descriptive statistics with multivariate logistic regression to determine demographic, disease, and health-related predictors of supplement use. MAIN RESEARCH VARIABLES: Use of dietary supplements and types of supplements taken. FINDINGS: Supplement use ranged from 50% among blood cancer survivors to 85% among melanoma skin cancer survivors, with an overall prevalence rate of 73%. Multivariate logistic regression revealed statistically significant associations (p values < 0.05) between supplement use and older age (>or= age 50), higher levels of education and physical activity, female gender, lower body mass index, and white ethnicity. CONCLUSIONS: Overall, a wide variety of supplements were reported, although multivitamins, calcium and vitamin D combinations, and antioxidant vitamin combinations were the most prevalent. Seventy-eight percent of supplement users took more than one supplement. IMPLICATIONS FOR NURSING: The findings support continued efforts by oncology nurses to identify the types of supplements cancer survivors are using. Nurses should caution against the use of individual supplements as well as combinations of different supplements containing nutrient quantities above recommended daily intake levels. Furthermore, oncology nurses and other healthcare professionals should be receptive to questions and prepared to initiate conversations with patients about their use of dietary supplements.
PURPOSE/ OBJECTIVES: To assess dietary supplement use and its association with demographic and health-related characteristics among cancer survivors and to investigate differences in supplement use patterns by cancer site. DESIGN: A cross-sectional survey. SETTING: Computer-assisted telephone survey. SAMPLE: 1,233 adult (ages 30-69) survivors participating in the Penn State Cancer Survivor Study who underwent an interviewer-administered questionnaire. METHODS: Descriptive statistics with multivariate logistic regression to determine demographic, disease, and health-related predictors of supplement use. MAIN RESEARCH VARIABLES: Use of dietary supplements and types of supplements taken. FINDINGS: Supplement use ranged from 50% among blood cancer survivors to 85% among melanoma skin cancer survivors, with an overall prevalence rate of 73%. Multivariate logistic regression revealed statistically significant associations (p values < 0.05) between supplement use and older age (>or= age 50), higher levels of education and physical activity, female gender, lower body mass index, and white ethnicity. CONCLUSIONS: Overall, a wide variety of supplements were reported, although multivitamins, calcium and vitamin D combinations, and antioxidant vitamin combinations were the most prevalent. Seventy-eight percent of supplement users took more than one supplement. IMPLICATIONS FOR NURSING: The findings support continued efforts by oncology nurses to identify the types of supplements cancer survivors are using. Nurses should caution against the use of individual supplements as well as combinations of different supplements containing nutrient quantities above recommended daily intake levels. Furthermore, oncology nurses and other healthcare professionals should be receptive to questions and prepared to initiate conversations with patients about their use of dietary supplements.
Authors: Cecile A Lengacher; Mary P Bennett; Kevin E Kip; Rosemary Keller; Melisa S LaVance; Lynette S Smith; Charles E Cox Journal: Oncol Nurs Forum Date: 2002 Nov-Dec Impact factor: 2.172
Authors: H Boon; M Stewart; M A Kennard; R Gray; C Sawka; J B Brown; C McWilliam; A Gavin; R A Baron; D Aaron; T Haines-Kamka Journal: J Clin Oncol Date: 2000-07 Impact factor: 44.544
Authors: Rosemary S Wold; Susan T Lopez; C Lillian Yau; Lisa M Butler; Shirley L Pareo-Tubbeh; Debra L Waters; Philip J Garry; Richard N Baumgartner Journal: J Am Diet Assoc Date: 2005-01
Authors: Shirley S Kishiyama; Marjorie J Leahy; Tracy A Zitzelberger; Robin Guariglia; Daniel P Zajdel; James F Calvert; Jeffrey A Kaye; Barry S Oken Journal: Altern Ther Health Med Date: 2005 May-Jun Impact factor: 1.305
Authors: Jacqueline S Marinac; Colleen L Buchinger; Lincoln A Godfrey; James M Wooten; Chao Sun; Sandra K Willsie Journal: J Am Osteopath Assoc Date: 2007-01
Authors: Jean K Brown; Tim Byers; Colleen Doyle; Kerry S Coumeya; Wendy Demark-Wahnefried; Lawrence H Kushi; Anne McTieman; Cheryl L Rock; Noreen Aziz; Abby S Bloch; Barbara Eldridge; Kathryn Hamilton; Carolyn Katzin; Amy Koonce; Julie Main; Connie Mobley; Marion E Morra; Margaret S Pierce; Kimberly Andrews Sawyer Journal: CA Cancer J Clin Date: 2003 Sep-Oct Impact factor: 508.702
Authors: LeQuyen Luc; Charlotte Baumgart; Edward Weiss; Lesley Georger; Christine B Ambrosone; Gary Zirpoli; Susan E McCann Journal: Public Health Nutr Date: 2014-05-27 Impact factor: 4.022
Authors: Pamela N Klassen; Benjamin A Goldenberg; Pascal Lambert; Kathy Vagianos; Christina A Kim Journal: Support Care Cancer Date: 2020-02-23 Impact factor: 3.603
Authors: Thomas Elsner; Ralph Muecke; Oliver Micke; Franz J Prott; Karsten Muenstedt; Anita Waldmann; Jan Geissler; Jutta Huebner Journal: J Cancer Res Clin Oncol Date: 2013-03-16 Impact factor: 4.553
Authors: Heather Greenlee; Marilyn L Kwan; Isaac J Ergas; Garrett Strizich; Janise M Roh; Allegra T Wilson; Marion Lee; Karen J Sherman; Christine B Ambrosone; Dawn L Hershman; Alfred I Neugut; Lawrence H Kushi Journal: BMC Cancer Date: 2014-05-29 Impact factor: 4.430